Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2008
06/12/2008CA2671524A1 Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration
06/12/2008CA2671492A1 Compositions and methods to treat cancer with cupredoxins and cpg rich dna
06/12/2008CA2671420A1 Method of forming a tablet
06/12/2008CA2671354A1 Tricyclic compound and medical use thereof
06/12/2008CA2671324A1 Indoles which act as via receptor antagonists
06/12/2008CA2671321A1 Means for improving cognitive functions and memory based on hydrogenated pyrido (4,3-b) indoles (variants), pharmacological means based thereon and method for the use thereof
06/12/2008CA2671317A1 Antiviral composition and method of use
06/12/2008CA2671311A1 Sulfamatobenzothiophene derivatives
06/12/2008CA2671177A1 Mixture and method for reducing cholesterol using hydrophobic microparticles
06/12/2008CA2671121A1 Stat3 inhibitor having anti-cancer activity and associated methods
06/12/2008CA2671049A1 Stroke recovery
06/12/2008CA2670908A1 4, 5, 6, 7-tetrahydro-thieno [3, 2-c] pyridine derivatives as h3 modulators
06/12/2008CA2670902A1 4,5,6,7-tetrahydro-thieno [2,3-c] pyridines as h3 modulators
06/12/2008CA2670892A1 Substituted diazepan compounds as orexin receptor antagonists
06/12/2008CA2670887A1 Modified release ibuprofen solid oral dosage form
06/12/2008CA2670886A1 Oral transmucosal nicotine dosage form
06/12/2008CA2670870A1 Antibacterial polycyclic urea compounds
06/12/2008CA2670791A1 Crystalline potassium salt of lipoxin a4 analogs
06/12/2008CA2670788A1 A2a adenosine receptor antagonists
06/12/2008CA2670767A1 Inhibitors of akt activity
06/12/2008CA2670746A1 Intraocular drug delivery systems
06/12/2008CA2670741A1 Combination of an hdac inhibitor and an antimetabolite
06/12/2008CA2670678A1 New crystalline forms
06/12/2008CA2670671A1 Spiro-piperidine derivatives
06/12/2008CA2670593A1 Treatment of anxiety with eszopiclone
06/12/2008CA2670491A1 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy
06/12/2008CA2670375A1 Substituted pyrimidines and their use as jnk modulators
06/12/2008CA2670345A1 Thrombopoietin mimetics
06/12/2008CA2670342A1 N-oxides of 4,5-epoxy-morphinanium analogs
06/12/2008CA2670139A1 Indoles
06/12/2008CA2670001A1 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression
06/12/2008CA2669996A1 Pyrrol derivatives, preparation and use of the same in therapy
06/12/2008CA2669871A1 Anti-microorganism terpenic composition
06/12/2008CA2669829A1 Antibacterial quinoline derivatives
06/12/2008CA2669819A1 Antibacterial quinoline derivatives
06/12/2008CA2669590A1 2-aminoquinolines as 5-ht(5a) receptor antagonists
06/12/2008CA2668942A1 Means and method for raising improved immune response
06/12/2008CA2668558A1 Antibacterial quinoline derivatives
06/12/2008CA2668520A1 Antibacterial quinoline derivatives
06/12/2008CA2668517A1 Antibacterial quinoline derivatives
06/12/2008CA2668515A1 Antibacterial quinoline derivatives
06/12/2008CA2668512A1 Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
06/12/2008CA2668196A1 Substituted 2,5-dfflydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands
06/12/2008CA2667510A1 Methods for treating disruptive behavior disorders
06/12/2008CA2667482A1 Methods for treating pain with reduced nausea and vomiting
06/12/2008CA2667372A1 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-one as cb1 receptor modulators
06/12/2008CA2667210A1 1,5-diphenyl-3-pyridinylmethylamino-1,5-dihydropyrrolidin-2-one as a cb-1 receptor modulator
06/12/2008CA2666972A1 Method to enhance tissue regeneration
06/12/2008CA2665924A1 Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
06/12/2008CA2665841A1 Pharmaceutical compositions
06/12/2008CA2664940A1 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
06/12/2008CA2664271A1 Polymeric short interfering rna conjugates
06/12/2008CA2664219A1 Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
06/12/2008CA2664112A1 Novel substituted diaza-spiro-pyridinone derivatives for use in mch-1 mediated diseases
06/12/2008CA2659895A1 Improved method for synthesizing lamotrigine
06/12/2008CA2655541A1 Methods and compositions for producing anti-androgenic effects
06/11/2008EP1930420A1 Isolated nucleic acid molecules encoding a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
06/11/2008EP1930341A1 Agent for amelioration of insulin resistance
06/11/2008EP1930340A1 Antiproliferative activity of G-rich oligonucleotides and method of using the same to bind to nucleolin
06/11/2008EP1930335A1 Cephalosporines having cyclic aminoguanidine substituents as Antibiotics
06/11/2008EP1930330A1 Pleuromutilin derivatives as antimicrobials
06/11/2008EP1930323A1 Biphenyl compounds useful in the synthesis of muscarinic receptor antagonists
06/11/2008EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain
06/11/2008EP1930320A1 Novel fused pyrrole derivative
06/11/2008EP1930319A1 Proline derivatives and use thereof as drugs
06/11/2008EP1930308A1 Pharmaceutical agents for the treatment of cerebral amyloidosis
06/11/2008EP1930046A1 Retinol binding protein and transthyretin modulators for treating diabetes
06/11/2008EP1930030A1 Pulse preparation having improved disintegration properties in vivo
06/11/2008EP1930028A1 Non-invasive drug delivery system targeting posterior eye tissue using solid composition
06/11/2008EP1930027A2 A composition of sodium channel blocking compound
06/11/2008EP1930023A2 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
06/11/2008EP1930022A1 Treatment of bladder fibrosis with antibodies against alpha V beta 6 integrin
06/11/2008EP1930021A2 Novel amide derivatives as growth hormone secretagogues
06/11/2008EP1930015A1 Use of carrageenan for treating rhinovirus infections
06/11/2008EP1930014A1 Agent for amelioration of insulin resistance
06/11/2008EP1930013A1 Agent for amelioration of insulin resistance
06/11/2008EP1930012A1 Cellooligosaccharide-containing composition
06/11/2008EP1930011A2 Crystalline form of ibandronate sodium
06/11/2008EP1930010A1 Application of estradiol valerate or 17ß-estradiol in combination with dienogest for oral therapy to maintain and/or increase the female libido
06/11/2008EP1930009A2 Methods and compositions for treating male erectile dysfunction
06/11/2008EP1930008A1 Sable composition of benazepril hydrochloride
06/11/2008EP1930007A1 Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias
06/11/2008EP1930006A1 Method for production of quinolone-containing lyophilized preparation
06/11/2008EP1930005A1 Stabilized formulation of selective ligands of retinoic acid gamma-receptors
06/11/2008EP1930004A1 Use of epothilones in the treatment of osteoporosis and related diseases
06/11/2008EP1930003A1 Pharmaceutical form containing methocarbamol, meloxicam and betamethasone
06/11/2008EP1930002A1 Use of hydroxybenzoic acid ester and analogues for the manufacture of a mendicament for the prevention and treatment of virus infection
06/11/2008EP1930001A1 Pharmaceutical for use in prevention and/or treatment of bowel disease
06/11/2008EP1930000A1 Combination of organic compounds
06/11/2008EP1929999A1 Use of agomelatine to obtain medication aimed at treating Smith-Magenis Syndrome
06/11/2008EP1929998A2 Controlled release solid dispersions of carvedilol
06/11/2008EP1929997A1 Oxcarbazepine formulations
06/11/2008EP1929291A2 Estriol therapy for autoimmune and neurodegenerataive diseases and disorders
06/11/2008EP1929014A1 Methods of altering an immune response induced by cpg oligodeoxynucleotides
06/11/2008EP1928993A1 Proanthocyanidin tannin composition, production method thereof and use of same
06/11/2008EP1928920A2 Improved stabilizer cyanoacrylate formulations
06/11/2008EP1928913A2 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques
06/11/2008EP1928894A1 Novel c18 modified retrosteroids as progesterone receptor modulator compounds
06/11/2008EP1928893A2 Triazole compounds and methods of making and using the same
06/11/2008EP1928892A2 Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
1 ... 3227 3228 3229 3230 3231 3232 3233 3234 3235 3236 3237 3238 3239 3240 3241 3242 3243 3244 3245 3246 3247 ... 7860